Skip to main content

previous disabled Page of 182
and
  1. Article

    Open Access

    Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia

    Qian Wu, **aofei Yang, **gren Zhang, Mengxing Xue, Xueqing Dou in Blood Cancer Journal (2024)

  2. No Access

    Article

    A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells

    Immunotherapies, including chimeric antigen receptor (CAR) T cells and bispecific antibodies (BsAbs), encounter several challenges in the management of acute myeloid leukemia (AML), including limited persisten...

    Zhifeng Yan, Runxia Gu, Haotian Ma, Nianci Chen, Ting Zhang, Yingxi Xu in Cellular Oncology (2024)

  3. Article

    Open Access

    Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion radiotherapy boost for high-grade gliomas: a retrospective study

    This study aimed to compare the survival outcome and side effects in patients with primary high-grade glioma (HGG) who received carbon ion radiotherapy (CIRT) alone or as a boost strategy after photon radiatio...

    **aoJun Li, YanShan Zhang, YanCheng Ye, SuQing Tian, TingChao Hu, HongYu Chai in BMC Cancer (2024)

  4. Article

    Open Access

    Investigating distinct clinical features and constructing a nomogram model for survival probability in adults with cerebellar high-grade gliomas

    The clinical features of cerebellar high-grade gliomas (cHGGs) in adults have not been thoroughly explored. This large-scale, population-based study aimed to comprehensively outline these traits and construct ...

    Tao Chang, Rui Zhang, Jiahao Gan, Yuan Yang, Yanhui Liu, Yan Ju, **aodong Niu in BMC Cancer (2024)

  5. Article

    Open Access

    Nomogram for predicting the probability of rectal anastomotic re-leakage after stoma closure: a retrospective study

    In this study, we aimed to identify the risk factors in patients with rectal anastomotic re-leakage and develop a prediction model to predict the probability of rectal anastomotic re-leakage after stoma closure.

    Yuegang Li, Gang Hu, **zhu Zhang, Wenlong Qiu, Shiwen Mei, **shan Wang in BMC Cancer (2024)

  6. Article

    Open Access

    An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer

    The prognostic and therapeutic implications of endothelial cells (ECs) heterogeneity in prostate cancer (PCa) are poorly understood.

    Bing-Biao Lin, Qingqing Huang, Binyuan Yan, Mingcheng Liu in British Journal of Cancer (2024)

  7. Article

    Open Access

    eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

    Extracellular heat shock protein 90 AA1(eHSP90α) is intricately linked to tumor progression and prognosis. This study aimed to investigate the difference in the value of eHSP90α in post-treatment response asse...

    Yingzhen Bian, Haizhou Liu, **glei Huang, Zhaorong Feng, Yanyan Lin in BMC Cancer (2024)

  8. Article

    Open Access

    Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy

    Yu-An Li, Chuan Zhao, **g-**g Ge, Cheng Li, Feng-Jun Xue, Shao-Pei Qi in BMC Cancer (2024)

  9. Article

    Open Access

    Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies

    Numerous epidemiological investigations have explored the impact of body composition on the effectiveness of immune checkpoint inhibitors (ICIs) in urological malignancies (UM) patients, yielding conflicting f...

    Wangbin Ma, Qiao Shi, Lilong Zhang, Zhendong Qiu, Tianrui Kuang in BMC Cancer (2024)

  10. Article

    Open Access

    Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients

    Glioma is the most common primary brain tumor with high mortality and disability rates. Recent studies have highlighted the significant prognostic consequences of subty** molecular pathological markers using...

    **an **e, Chen Luo, Shuai Wu, Wanyu Qiao, Wei Deng, Lei **, Junfeng Lu in BMC Cancer (2024)

  11. Article

    Open Access

    Selective anti-tumor activity of glutathione-responsive abasic site trap** agent in anaplastic thyroid carcinoma

    Anaplastic thyroid carcinoma (ATC) is a rare but highly aggressive thyroid cancer with poor prognosis. Killing cancer cells by inducing DNA damage or blockage of DNA repair is a promising strategy for chemothe...

    **yan Chai, Mengxue Su, Ruiguo Zhang, Ning Li, Yuanyuan Jia, Wei Zheng in BMC Cancer (2024)

  12. Article

    Open Access

    Clinical applications of telemedicine services using a regional telemedicine platform for cancer treatment: a cross-sectional study

    Telemedicine is beneficial for improving treatment efficiency and reducing medical expenses of cancer patients. This study focuses on cancer patients participating in teleconsultations through a regional telem...

    Fangfang Cui, Xu Zhang, **anying He, Dongqing Liu, **ming Shi, Ming Ye in BMC Cancer (2024)

  13. Article

    Open Access

    Exploring the causal association between uric acid and lung cancer in east Asian and European populations: a mendelian randomization study

    Lung cancer still ranks first in the mortality rate of cancer. Uric acid is a product of purine metabolism in humans. Its presence in the serum is controversial; some say that its high levels have a protective...

    ** Lin, Linxiang Zhang, **aohui Tang, Jihuang Wang in BMC Cancer (2024)

  14. Article

    Open Access

    Differentiation of glioma and solitary brain metastasis: a multi-parameter magnetic resonance imaging study using histogram analysis

    Differentiation of glioma and solitary brain metastasis (SBM), which requires biopsy or multi-disciplinary diagnosis, remains sophisticated clinically. Histogram analysis of MR diffusion or molecular imaging h...

    Yifei Su, Rui Cheng, **xia Guo, Miaoqi Zhang, Junhao Wang, Hongming Ji in BMC Cancer (2024)

  15. Article

    Open Access

    Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1

    Drug resistance remains a significant challenge in the treatment of pancreatic cancer. The development of drug-resistant cell lines is crucial to understanding the underlying mechanisms of resistance and devel...

    Cheng Yu, Yuanhui Su, **n Miao, Changpeng Chai, Huan Tang, Lu Li, Jianfeng Yi in BMC Cancer (2024)

  16. Article

    Open Access

    Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation

    Esophageal squamous cell carcinoma (ESCC) is a prevalent tumor in the gastrointestinal tract, but our understanding of the molecular mechanisms underlying ESCC remains incomplete. Existing studies indicate tha...

    Jianmin Gu, Shaoyuan Zhang, Dong Lin, Wenhan Wang, **ke Cheng in Cellular Oncology (2024)

  17. No Access

    Article

    Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing

    Due to insufficient knowledge about key molecular events, Hepatocellular carcinoma (HCC) lacks effective treatment targets. Spliceosome-related genes were significantly altered in HCC. Oncofetal proteins are i...

    Qipeng Wu, Ruyan Liao, Chunmeng Miao, Muhammad Hasnat, Le Li in British Journal of Cancer (2024)

  18. No Access

    Article

    HLA-A+ tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma

    Immune checkpoint blockade (ICB) therapy provides remarkable clinical benefits for multiple cancer types. However, the overall response rate to ICB therapy remains low in esophageal squamous cell carcinoma (ES...

    Dandan Zhang, Dongxian Jiang, Li** Jiang, Jiakang Ma in British Journal of Cancer (2024)

  19. No Access

    Article

    KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer

    DNMT3A is a crucial epigenetic regulation enzyme. However, due to its heterogeneous nature and frequent mutation in various cancers, the role of DNMT3A remains controversial. Here, we determine the role of DNM...

    Yingxi Zhao, Yonghao Zheng, **jiang Fu, Jiayu Zhang, Hui Shao in British Journal of Cancer (2024)

  20. Article

    Open Access

    Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma

    To explore the correlation between effective dose to immune cells (EDIC) and vertebral bone marrow dose and hematologic toxicity (HT) for esophageal squamous cell carcinoma (ESCC) during neoadjuvant chemoradio...

    Meng Zhang, Zhenjiang Li, Yong Yin in BMC Cancer (2024)

previous disabled Page of 182